These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2560329)

  • 1. NAD synthesis by erythrocytes in phosphoribosylpyrophosphate synthetase (PRPPs) superactivity.
    Micheli V; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():1-7. PubMed ID: 2560329
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of nicotinamide-adenine dinucleotide synthesis in erythrocytes of patients with hypoxanthine-guanine phosphoribosyltransferase deficiency and a patient with phosphoribosylpyrophosphate synthetase superactivity.
    Micheli V; Simmonds HA; Ricci C
    Clin Sci (Lond); 1990 Feb; 78(2):239-45. PubMed ID: 2155755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoribosylpyrophosphate synthetase superactivity: detection, characterization of underlying defects, and treatment.
    Becker MA
    Adv Exp Med Biol; 1984; 165 Pt A():91-96. PubMed ID: 6326492
    [No Abstract]   [Full Text] [Related]  

  • 4. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
    Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal purine and pyrimidine metabolism in inherited superactivity of PRPP synthetase.
    Bory C; Chantin C; Boulieu R
    Adv Exp Med Biol; 1994; 370():15-8. PubMed ID: 7660879
    [No Abstract]   [Full Text] [Related]  

  • 7. PRPP synthetase superactivity in lymphoblast lines.
    Becker MA; Losman MJ; Rimon D; Kim M
    Adv Exp Med Biol; 1986; 195 Pt A():51-8. PubMed ID: 3014839
    [No Abstract]   [Full Text] [Related]  

  • 8. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
    Becker MA; Losman MJ; Simmonds HA
    Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():15-22. PubMed ID: 2483028
    [No Abstract]   [Full Text] [Related]  

  • 10. Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and gout.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Ciba Found Symp; 1977; (48):143-64. PubMed ID: 204460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible metabolic basis for GTP depletion in red cells of patients with PRPP synthetase superactivity.
    Giacomello A; Salerno C
    Adv Exp Med Biol; 1991; 309B():253-6. PubMed ID: 1664182
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence of a new type of phosphoribosylpyrophosphate synthetase with abnormal kinetic properties in hyperuricemias.
    Mousson B; Baltassat P
    Adv Exp Med Biol; 1984; 165 Pt B():1-4. PubMed ID: 6326493
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel PRPS1 gain-of-function mutation in a patient with congenital hyperuricemia and facial anomalies.
    Porrmann J; Betcheva-Krajcir E; Di Donato N; Kahlert AK; Schallner J; Rump A; Schröck E; Dobritzsch D; Roelofsen J; van Kuilenburg ABP; Tzschach A
    Am J Med Genet A; 2017 Oct; 173(10):2736-2742. PubMed ID: 28742244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Am J Med; 1988 Sep; 85(3):383-90. PubMed ID: 2843048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PRPP synthetase superactivity].
    Fujimori S
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
    Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase.
    Willis RC; Nord LD; Fujitaki JM; Breen TS; Matsumoto SS
    Adv Exp Med Biol; 1989; 253B():7-12. PubMed ID: 2558549
    [No Abstract]   [Full Text] [Related]  

  • 20. The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.
    Takeuchi F; Hanaoka F; Yano E; Yamada M; Horiuchi Y; Akaoka I
    Hum Genet; 1981; 58(3):322-30. PubMed ID: 6276287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.